Guru Ownership Trend
Guru Analysis for Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $153.63 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $31.28 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Chuck Royce reduced exposure by 3.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Axsome Therapeutics, Inc. (AXSM)
Major holders include Steven Cohen ($101.95 M), Renaissance Technologies (RenTech) ($64.13 M), Cliff Asness ($27.91 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 987,357 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $31.28 M, with 6 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited AXSM. The total reported sell value was $2.74 M.
Yes, 2 managers opened new positions in AXSM, and 4 increased their existing holdings. The total reported buy value was $34.02 M.
